Pericapsular nerve group block in patients on antithrombotic drugs: A reply to ESAIC/ESRA guidelines
- PMID: 36924169
- DOI: 10.1097/EJA.0000000000001800
Pericapsular nerve group block in patients on antithrombotic drugs: A reply to ESAIC/ESRA guidelines
Comment on
-
Regional anaesthesia in patients on antithrombotic drugs: Joint ESAIC/ESRA guidelines.Eur J Anaesthesiol. 2022 Feb 1;39(2):100-132. doi: 10.1097/EJA.0000000000001600. Eur J Anaesthesiol. 2022. PMID: 34980845
References
-
- Kietaibl S, Ferrandis R, Godier A, et al. Regional anaesthesia in patients on antithrombotic drugs: Joint ESAIC/ESRA guidelines. Eur J Anaesthesiol 2022; 39:100–132.
-
- Gogarten W, Vandermeulen E, Van Aken H, et al. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol 2010; 27:999–1015.
-
- Horlocker TT, Vandermeuelen E, Kopp SL, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition). Reg Anesth Pain Med 2018; 43:263–309.
-
- Pascarella G, Costa F, Del Buono R, et al. Impact of the pericapsular nerve group (PENG) block on postoperative analgesia and functional recovery following total hip arthroplasty: a randomised, observer-masked, controlled trial. Anaesthesia 2021; 76:1492–1498.
-
- Del Buono R, Padua E, Pascarella G, et al. Pericapsular nerve group block: an overview. Minerva Anestesiol 2021; 87:458–466.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
